Go to OCA Home
Login to your account

Three incoming non-executive directors

20 December 2022

~ 2 minutes

Ovarian Cancer Australia is thrilled to announce the appointment of Melissa McClusky, Andrew Jolly and Richard Gosper to the Board of Ovarian Cancer Australia.  

In welcoming these appointments, Ovarian Cancer Australia Chair, Meghan Speers, highlighted that Ovarian Cancer Australia’s Board of Directors dedicates a significant amount of energy and expertise, working on an honorary basis towards Ovarian Cancer Australia’s vision to save lives and ensure no woman with ovarian cancer walks alone.  

“The three incoming Directors will join the Board at a pivotal time of growth and development in programs and services and in the organisation’s digital footprint. Each adds a unique area of expertise and knowledge to our organisation and brings very strong digital acumen. I look forward to working alongside our new Directors to ensure Ovarian Cancer Australia continues to meet our strategic priorities and improve the lives of everyone impacted by ovarian cancer. “ Ms Speers said 

“We have come so far as an organisation, but there is still so much work to be done. Ovarian cancer is Australia’s deadliest female cancer with a five-year survival rate of just 49%. We look forward to working together to improve the lives of people affected by ovarian cancer and change the story of what it means to receive an ovarian cancer diagnosis” 

Ovarian Cancer Australia today welcomes: 

Melissa McClusky is a partner at KPMG. With over 25 years of management and leadership experience in a career spanning both public and private sector organisations, Mel brings a strong focus on digital programs and excellence in service delivery. 

Andrew Jolly is a Director at PwC based in Melbourne. He is an experienced technology professional with significant senior digital and program delivery experience across the private and public sectors. Andrew’s experience assisting complex organisations with digital transformation and delivery will be beneficial as Ovarian Cancer Australia continues to navigate the challenging and exciting changing environment. 

Richard Gosper is an Associate Partner at Bain & Company, a global management consulting firm and brings experience in strategy development and digital acumen. His experience working with complex organisations will be beneficial as Ovarian Cancer Australia continues to influence and participate within the broader cancer ecosystem.

These three incoming Directors will join Ovarian Cancer Australia’s existing Board of Directors which includes Chair Meghan Speers, Professor Juliet Bourke, Jo-Ann Hicks, Marise Maltman and Professor Karen Strickland. 

Acknowledgement flags

Ovarian Cancer Australia acknowledges the Traditional Owners of the land where our office is located, the Wurundjeri people of the Kulin Nation and we pay our respects to Elders past and present.